---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "WHSKpyz4gvb+EcQJt5POexSrkGDhSutHgq0WLWgM7iIXoE17fcSJAbiGRWeicP+o40ew6w3Ayfjf03nCPFTQOxVMD7dffVm94YrmGqqWJC7q0qurSEUqO1lKjPigkLDm4bGnVIFhGGRB4p6WfoHcFqBQdPhkR40YpYDgvrVt4cUpWnkZtYw1ob4eLxsswaAcptH4oq6TVQphoAcwnzm+riuq/81J5A0NhkLWoL2SYp8sYEJ5/PhBKlrdj3NyjX81QQW7BmUJH9xhDapB3LS5zM+mekUNseLwT5/UZXXwrpp91IRS2nXYuAgVzH65zPlP87T5TxqlflUNUQJ+QwNrGiJLFX0RI+PrsHeLD2m7YWA=;KtXjhmw83RVYfcTWHS67jA=="
---

